V Wealth Advisors’s Globus Medical GMED Stock Holding History

V Wealth Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,090	Closed	-$561K	–	470
2021 Q1	$561K	Sell	9,090 -700	-7%	-$44.3K	0.1%	228
2020 Q4	$639K	Sell	9,790 -340	-3%	-$19.5K	0.13%	178
2020 Q3	$502K	Sell	10,130 -800	-7%	-$41.3K	0.35%	79
2020 Q2	$521K	Buy	+10,930	New	+$527K	0.14%	179

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

V Wealth Advisors's GMED Position: Q2 2021 in Review

V Wealth Advisors sold out of Globus Medical (GMED) in Q2 2021, closing a stake of 9,090 shares — an estimated $561K sold.

V Wealth Advisors first reported a position in GMED in Q2 2020 and held it in 4 quarters. The position peaked at $639K in Q4 2020. 354 funds tracked by Wall St. Rank hold GMED as of Q2 2021.

V Wealth Advisors reported no remaining Globus Medical position as of Q2 2021 after selling out during the quarter.
V Wealth Advisors sold 9,090 Globus Medical shares in Q2 2021, an estimated $561K.
V Wealth Advisors first reported a position in Globus Medical in Q2 2020 and held it in 4 quarters.
V Wealth Advisors's Globus Medical position peaked at $639K in Q4 2020.
354 funds tracked by Wall St. Rank held Globus Medical as of Q2 2021.

Based on V Wealth Advisors's 13F filing for Q2 2021, filed 27 Jul 2021.